However, it seems so oversold and if price pushes lower I will likely re-enter, the stock has a strong pipeline of goods and has had some good news recently (Amondys 45 FDA approval) which hasnt really been reflected in the stock price.
RSI is touching oversold Average Analyst price target is still $130 Price at multi year lows
I think taking multiple small positions is the way to play this, to scale in, and allow for protection from the continuation of the sell off in the short term
עסקה סגורה: הגיע לסטופ
⋅
This trade never really got going so I am out of it Keeping Sarepta on my watchlist